Amgen/UCB reveal new osteoporosis drug data
But romosozumab missed secondary endpoint of non-vertebral fractures
X
Amgen/UCB reveal new osteoporosis drug data
https://pharmaphorum.com/news/amgenucb-reveal-new-osteoporosis-drug-data/
But romosozumab missed secondary endpoint of non-vertebral fractures